Cut-off value of mal-apposition volume and depth for resolution at early phase of acute incomplete stent apposition after CoCr-EES implantation.
Aged
Cardiovascular Agents
/ administration & dosage
Chromium Alloys
Coronary Artery Disease
/ diagnostic imaging
Coronary Vessels
/ diagnostic imaging
Drug-Eluting Stents
Everolimus
/ administration & dosage
Female
Humans
Male
Middle Aged
Percutaneous Coronary Intervention
/ adverse effects
Predictive Value of Tests
Prospective Studies
Prosthesis Design
Registries
Reproducibility of Results
Time Factors
Tomography, Optical Coherence
Treatment Outcome
Cobalt–chromium everolimus-eluting stent
Coronary artery disease
Incomplete stent apposition
Late acquired mal-apposition
Optical coherence tomography
Journal
The international journal of cardiovascular imaging
ISSN: 1875-8312
Titre abrégé: Int J Cardiovasc Imaging
Pays: United States
ID NLM: 100969716
Informations de publication
Date de publication:
Nov 2019
Nov 2019
Historique:
received:
12
02
2019
accepted:
21
06
2019
pubmed:
1
7
2019
medline:
24
12
2019
entrez:
1
7
2019
Statut:
ppublish
Résumé
The purpose of this study was to clarify a cut-off value for acute incomplete stent apposition (ISA) volume and maximum-depth to predict ISA resolution at 1- and 3-month follow-up in patients treated with cobalt-chromium everolimus-eluting stents. In total, 95 cases and 103 stents were registered in the MECHANISM-Elective sub-study. Acute ISA-volume was measured by the trapezoid rule. ISA resolution of cut-off value at 1- and 3-month was estimated by ISA-volume and maximum-depth using receiver operatorating characteristic curve analysis. The total number of analysed acute ISAs was 202 in the 1-month group and 225 in the 3-month group. A total of 123 ISAs at 1-month and a total of 169 ISAs at 3-month had been resolved. The cut-off value of ISA resolution by ISA-volume was 0.169 mm
Identifiants
pubmed: 31256285
doi: 10.1007/s10554-019-01657-y
pii: 10.1007/s10554-019-01657-y
doi:
Substances chimiques
Cardiovascular Agents
0
Chromium Alloys
0
Everolimus
9HW64Q8G6G
Types de publication
Comparative Study
Journal Article
Multicenter Study
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1979-1987Références
EuroIntervention. 2011 Apr;6(9):1037-45
pubmed: 21518674
J Am Coll Cardiol. 2015 Apr 7;65(13):1298-1310
pubmed: 25681754
Eur Heart J Cardiovasc Imaging. 2013 Sep;14(9):865-75
pubmed: 23291393
Circ Cardiovasc Interv. 2014 Feb;7(1):88-96
pubmed: 24425586
Catheter Cardiovasc Interv. 2010 Feb 1;75(2):202-6
pubmed: 19937788
Circulation. 2008 Sep 9;118(11):1138-45
pubmed: 18725485
Eur Heart J. 2010 Jun;31(12):1470-6
pubmed: 20363765
Circulation. 2011 Apr 5;123(13):1400-9
pubmed: 21422389
J Am Coll Cardiol. 2014 Sep 2;64(9):953-4
pubmed: 25169183
Lancet. 2012 Oct 27;380(9852):1482-90
pubmed: 22951305
Int J Cardiovasc Imaging. 2014 Jun;30(5):857-65
pubmed: 24748583
Arterioscler Thromb Vasc Biol. 2007 Jul;27(7):1500-10
pubmed: 17510464
Circ Cardiovasc Interv. 2012 Feb 1;5(1):20-9, S1-8
pubmed: 22319063
Am J Cardiol. 2012 Oct 15;110(8):1106-12
pubmed: 22748353
Clin Res Cardiol. 2010 Oct;99(10):639-44
pubmed: 20407905
Cell Mol Biol (Noisy-le-grand). 2016 Jan 19;62(1):51-5
pubmed: 26828987
Circulation. 2007 May 8;115(18):2379-81
pubmed: 17485592
Heart Vessels. 2016 Aug;31(8):1247-56
pubmed: 26334709
EuroIntervention. 2012 Nov 22;8(7):823-9
pubmed: 23034247
Eur Heart J Cardiovasc Imaging. 2015 Jan;16(1):23-8
pubmed: 25342855
Heart. 2012 Oct;98(20):1529-36
pubmed: 23001063
JACC Cardiovasc Interv. 2015 Aug 17;8(9):1248-1260
pubmed: 26292590
JACC Cardiovasc Interv. 2010 May;3(5):531-9
pubmed: 20488410
Atherosclerosis. 2017 Oct;265:117-123
pubmed: 28881269